You may think that QR codes aren’t new. But it’s actually quite something new in our field.
We as statisticians, should not just leave the use of QR code to other functions such as medical writing. Instead, let’s leverage this tool to have an impact and improve our output.
Listen while we discuss the following points:
[Read more…] about Posters, flyers, papers and how you can use QR codes to enhance themToday, we have a special guest, Shanti. Learn while she shares with us her vast experience in the pharmaceutical industry collected over 25 years. She held various positions inside and outside of statistics organization.
Join us while we discuss the following points:
[Read more…] about Taking on leadership roles outside of statisticsWhen I started my career as a statistician in the clinical world, I was wondering about safety analysis. I thought it’s always the same – count the patients with an event – job done! Then just repeat.
But it’s not that simple, especially in more complex situation where you have different follow-up times. Then the patients that stay longer on treatment as they benefit from it, also get more adverse events. Naively counting the patients with events or the number of events may make the beneficial treatment look worse. So, how can you account for this?
Join us while we dive deep into the following points:
[Read more…] about The analysis of adverse events done right – SAVVYWhy spend part of your career in non-clinical statistics?
What are the advantages?
What is the importance of having a variety of tools?
In this episode, Sam and I talk about the advantages of spending time in the non-clinical areas and other important points:
[Read more…] about Why spend part of your career, as a pharmaceutical statistician in the non-clinical areas?R versus SAS – which is the better tool?
Today, we talk about a controversial topic. If you go online and look into social media, you’ll find a lot of data scientists that talk about R versus Python. In medical and clinical research, it’s more about R versus SAS.
For this discussion, we have Sam Gardner and Thomas Neitmann representing SAS and R, respectively.
Join us while we discuss the following points:
[Read more…] about R vs SAS – which is the better tool in pharmaceutical researchWe may use movements and transformations as an add-on to the design.
However, this type of implementations can be more important than that.
Motion in visualizations is not a gratuitous element. On the contrary, animations can influence how users interact and understand our designs.
Join us while Irene and I talk about how animations and movements can create a lot of advantages such as the following:
[Read more…] about Animations and movements – how to use them effectively with data visualization
